Asia Pacific Nucleic Acid Isolation and Purification Market

The Asia Pacific nucleic acid isolation and purification market is projected to reach USD 2.65 billion by 2030 from USD 1.61 billion in 2025, at a CAGR of 10.5% during the forecast period. Major factors supporting growth in the Asia Pacific nucleic acid isolation and purification market include rising government backing and institutional investments in genomics, precision medicine, and life sciences research. Several country-level programs and funding initiatives are strengthening population genomics, cancer genomics, and rare disease testing, thereby expanding the routine DNA/RNA extraction needs across both clinical and academic labs.

The Asia Pacific nucleic acid isolation and purification market is competitive. Prominent players in the market are Thermo Fisher Scientific Inc. (US), QIAGEN (Germany), F. Hoffman-La Roche Ltd. (Switzerland), Danaher Corporation (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), and Takara Bio Inc. (Japan), among others.

To know about the assumptions considered for the study download the pdf brochure

In September 2023, QIAGEN launched two new nucleic acid extraction kits: the QIAwave RNeasy Plus Mini Kit and QIAwave DNA/RNA Mini Kit, eco-friendlier versions of the RNeasy Plus Mini Kit and the All DNA/RNA Mini Kit. In August 2023, Danaher entered into a definitive agreement to acquire all the outstanding shares of Abcam. Through this development, Abcam is expected to operate as a standalone operating company within Danaher’s Life Sciences segment.

Thermo Fisher Scientific Inc. is a key player in the Asia Pacific nucleic acid isolation and purification market. It offers a broad portfolio that is suitable for both routine diagnostics and high-throughput testing. KingFisher automated purification systems are widely used in large hospital laboratories, diagnostic chains, and reference laboratories that require fast and repeatable extraction. Demand is supported by MagMAX magnetic bead kits, which are designed for automation and are commonly used in viral/pathogen workflows, respiratory panels, and other NAAT testing applications.

QIAGEN is a leading player in the Asia Pacific nucleic acid isolation and purification market, supported by its strong installed base in hospital labs, reference labs, and research institutes. The company is widely preferred for standardized and reliable extraction, especially in routine PCR/qPCR and sequencing sample preparation. On the automation side, QIAGEN’s QIAsymphony platform enables high-throughput labs in the Asia Pacific to scale DNA/RNA extraction with repeatability and reduced hands-on time.

F. Hoffmann-La Roche is an important player in the Asia Pacific nucleic acid isolation and purification market, mainly through its strong footprint in clinical molecular diagnostics. Many large hospitals and reference labs in the Asia Pacific region prefer Roche as it offers an integrated, end-to-end approach where extraction performance is aligned with downstream PCR workflows. This is important in routine, high-volume settings where labs prioritize consistency, traceability, and low hands-on time. Roche’s MagNA Pure automated nucleic acid purification systems support standardized DNA/RNA extraction for infectious disease testing and broader molecular tests.

Market Ranking

The Asia Pacific nucleic acid isolation and purification market is competitive, with suppliers strengthening their market share through a combination of proven chemistries, broader automation footprints, and repeat demand for consumables. With its strong portfolio of magnetic bead- and column-based kits and a wide installed base of KingFisher systems across hospital labs, large diagnostic chains, reference labs, and research centers, Thermo Fisher Scientific is a key company in the region. QIAGEN remains another important player. Its growth is aided by the widespread adoption of QIAamp and RNeasy/DNeasy kits, as well as automation platforms such as QIAsymphony and QIAcube. Roche Diagnostics is also a significant player in Asia, particularly in regulated clinical laboratory environments where customers prefer integrated, dependable workflows. Roche’s MagNA Pure systems are designed to ensure consistent extraction performance and rapid turnaround times.

Related Reports:

Asia Pacific Nucleic Acid Isolation and Purification Market by Product (Kits, Reagents, Instruments), Method (Column, Magnetic Beads), Type (Genomic DNA, Plasmid DNA), Application (Diagnostics, Personalized Medicine), End User (CROs) - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com